About Ensal
Ensal is a Healthcare company based in Mumbai (India) founded in 1992. It operates as an RD company manufacturing drugs for various therapeutic areas. It operates on a B2B model. The company has 12 employees. Its Indian entity Enzal Chemicals (India) Limited reported revenue of ₹27.70 Cr. Its focus areas include Pharmaceuticals, Drug Development and Therapeutics Manufacturing.
Company details
Ensal, based in Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, drug development, and therapeutics manufacturing. Operates as an RD company manufacturing drugs for various therapeutic areas. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- Employees 12
- SectorsHealthcare
- Website enzal.com
- Legal Name Enzal Chemicals (India) Limited
- Date of Incorporation 30 Jun, 1992
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹27.70 Cr
FY 2025 · +29% YoY
- Net Profit₹29.7 Lakh
FY 2025 · 1% margin
- EBITDA₹1.75 Cr
FY 2025 · 6% margin
- Employee Count12
Associated legal entities of Ensal
Ensal operates through Enzal Chemicals (India) Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Enzal Chemicals (India) Limited CIN U24110MH1992PLC067485 | Active | 30 Jun 1992 | Mumbai, Maharashtra | ₹27.7 Cr | 12 | 4 | View details |
Board of directors of Enzal Chemicals (India) Limited (Ensal)
Enzal Chemicals (India) Limited is the primary company behind Ensal. The board of Enzal Chemicals (India) Limited currently have 4 directors; the longest-serving is Arun Gupta Guruprasad, appointed in 1992. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arun Gupta Guruprasad DIN 00104564 | Managing Director | 30 Jun 1992 | 34 yrs 3 mo | Enzal Chemicals (India) Limited |
| Alpana Arun Gupta DIN 00104516 | Director | 03 Jan 1994 | 32 yrs 9 mo | Enzal Chemicals (India) Limited |
| Naveen Koolwal DIN 01038857 | Director | 01 Dec 2006 | 19 yrs 10 mo | Enzal Chemicals (India) Limited |
| Roop Narayan Koolwal DIN 11257322 | Director | 25 Aug 2025 | 1 yr 1 mo | Enzal Chemicals (India) Limited |
Financials of Ensal
Figures of Enzal Chemicals (India) Limited, the primary company behind Ensal, for FY 2025. Revenue was ₹27.70 Cr (+29% year on year). Net profit was ₹29.7 Lakh (1% margin). EBITDA was ₹1.75 Cr (6% margin). Revenue has grown at a compounded annual rate of +9% over three years and -3% over five years.
- ₹27.70 CrRevenue · FY 2025 · +29% YoY
- ₹29.7 LakhNet profit · 1% margin
- ₹1.75 CrEBITDA · 6% margin
- ₹95 LakhPaid-up capital
- 12Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- -3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Enzal Chemicals (India) Limited are on its company page.
Detailed financial statements for Ensal
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Ensal
Websites that share an audience with Ensal (enzal.com).
Websites whose visitors overlap most with Ensal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neulandlabs.com | 100% | 20.8K | #904,182 | View details | |
| u-g.com | 100% | 3.2K | #7,045,168 | View details | |
| arranchemical.ie | 100% | 1.8K | #9,179,397 | View details | |
| polydex.com | 100% | – | – | View details | |
| cedarburgpharma.com | 100% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Ensal
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Ensal (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ensal
Ensal was founded in 1992.
Ensal is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Ensal has 12 employees.
The primary company behind Ensal, Enzal Chemicals (India) Limited, reported revenue of ₹27.70 Cr for FY 2025, up 29% year on year.
Ensal, based in Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, drug development, and therapeutics manufacturing. Operates as an RD company manufacturing drugs for various therapeutic areas. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Ensal operates through Enzal Chemicals (India) Limited.
The legal entities of Ensal currently have 4 directors, including Naveen Koolwal, Alpana Arun Gupta, Arun Gupta Guruprasad and others.